Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in Pediatric Acute Lymphoblastic Leukemia
NCT02451774Phase 3Unknown
- Start
- Jan 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute lymphoblastic leukemia (ALL) comparing Pentoxifylline Plus Chemotherapy with Placebo Plus Chemotherapy (2 arms). Primary endpoint: Apoptosis measure by Flow Cytometry at 28 days. Status: unknown.
02
Drugs
pentoxifylline
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02451774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02451774.